自质子泵抑制剂 (ＰＰＩ)临床应用以来 ,酸相关性疾病的治疗进入了新的时期。尽管目前广泛应用的ＰＰＩ多能有效地解除患者的症状 ,但存在个体差异大、起效缓慢以及作用不稳定等缺点。近年来 ,国外已广泛应用新一代的ＰＰＩ雷贝拉唑。临床研究表明 ,雷贝拉唑具有独特的药理学特 Since the clinical application of proton pump inhibitors (PPI), the treatment of acid-related diseases has entered a new era. Although widely used PPI can effectively relieve the symptoms of patients, but there are individual differences, slow onset and the role of instability and other shortcomings. In recent years, a new generation of PPI rabeprazole has been widely used abroad. Clinical studies have shown that rabeprazole has a unique pharmacological special